Malignant Ascites: A Source of Therapeutic Protein Against Ovarian Cancer?

Oncotarget - United States
doi 10.18632/oncotarget.27185
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

Activation of LXRɑ/β by Cholesterol in Malignant Ascites Promotes Chemoresistance in Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Human Epididymis Protein 4 Immunostaining of Malignant Ascites Differentiates Cancer of Müllerian Origin From Gastrointestinal Cancer

Cancer cytopathology
Cancer ResearchOncology
2017English

Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas?

Oncologist
Cancer ResearchMedicineOncology
2002English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

PTH-022 Safety and Efficacy of Day Case Therapeutic Paracentesis for Malignant Ascites

Gut
Gastroenterology
2014English

Pathophysiology of Elevated Ascites Fluid Cholesterol in Malignant Ascites

Journal of Hepatology
Hepatology
1992English

Malignant Ascites: A Review of Pathogenesis and Management

Open Access Journal of Surgery
2017English

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Unique Proteome Signature of Post-Chemotherapy Ovarian Cancer Ascites-Derived Tumor Cells

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy